BrainGate™ Co. has a strong and diverse intellectual property portfolio, including exclusive rights to key patents surrounding neural interfaces and their use to control computers, prosthesis, and other devices. BrainGate™ Co. also has rights to intellectual property from related research projects conducted at leading Universities, including Brown, Emory, Columbia and MIT.
In addition to its unique patent portfolio, BrainGate™ Co. is also focused on the analysis and interpretation of neural recordings through software and neural network innovation. In the future, this capability could allow for the recording of electrical data for future analysis, a massive advantage for medical practitioners to study patient’s everyday patterns to determine medical treatment. For example, a potential use of this feature would be for a neurologist to study seizure patterns in a patient with epilepsy.
The following table includes a sample of our current patent portfolio. In addition to these patents, BrainGate™ Co. owns various trademarks including Bionics®, Neuroport® and Cerebus®. For more information on licensing our intellectual property, please contact us.